Tianjin Tianyao Pharmaceuticals Co., Ltd.

11
Strong Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001840
CNY
6.00
0.03 (0.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Tianjin Tianyao Pharmaceuticals Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
124.00
235.00
168.00
14.00
147.00
113.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-350.00
20.00
320.00
244.00
-49.00
-11.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
138.00
569.00
783.00
648.00
319.00
341.00
Cash Flow from Investing Activities
49.00
-76.00
-132.00
-198.00
-380.00
-584.00
Cash Flow from Financing Activities
14.00
-617.00
-564.00
-49.00
93.00
179.00
Net Cash Inflow / Outflow
201.00
-108.00
94.00
401.00
33.00
-65.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
15.00
8.00
0.00
1.00
-2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CNY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Tianjin Tianyao Pharmaceuticals Co., Ltd.
Figures in Million
Markets Mojo
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -75.73% vs -27.28% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
138.16
569.37
-75.73%